Evidence map›Paper›PMID 34351896›Full record

ReviewPLoS neglected tropical diseases2021

The clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations.

Igor Salerno Filgueiras, Amanda Torrentes de Carvalho, Daniela Prado Cunha, Dennyson Leandro Mathias da Fonseca, Nadia El Khawanky, Paula Paccielli Freire, Gustavo Cabral-Miranda, Lena F Schimke, Niels Olsen Saraiva Camara, Hans D Ochs and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. The Innate Defense in the Zika-Infected Placenta.Pathogens (Basel, Switzerland) · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Igor Salerno FilgueirasDepartment of Immunology, Institute of Biomedical Sciences of University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-3493-4464
Amanda Torrentes de CarvalhoDepartment of Immunobiology, Institute of Biology of Federal University of Fluminense, Niterói, Rio de Janeiro, Brazil.
Daniela Prado CunhaDepartment of Clinical Research, Instituto Fernandes Figueira, Fiocruz, Rio de Janeiro, Brazil.ORCID 0000-0002-5954-6054
Dennyson Leandro Mathias da FonsecaDepartment of Clinical Analyses and Toxicology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-2567-5808
Nadia El KhawankyDepartment of Hematology and Oncology, Faculty of Medicine, the University of Freiburg, Freiburg, Germany.
Paula Paccielli FreireDepartment of Immunology, Institute of Biomedical Sciences of University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-0649-8279
Gustavo Cabral-MirandaDepartment of Immunology, Institute of Biomedical Sciences of University of São Paulo, São Paulo, Brazil.
Lena F SchimkeDepartment of Immunology, Institute of Biomedical Sciences of University of São Paulo, São Paulo, Brazil.
Niels Olsen Saraiva CamaraDepartment of Immunology, Institute of Biomedical Sciences of University of São Paulo, São Paulo, Brazil.ORCID 0000-0001-5436-1248
Hans D OchsDepartment of Pediatrics, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, Washington, United States of America.
Jean Pierre Schatzmann PeronDepartment of Immunology, Institute of Biomedical Sciences of University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-1638-8866
Otávio Cabral-MarquesDepartment of Immunology, Institute of Biomedical Sciences of University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-3183-6236
Zilton Farias Meira de VasconcelosDepartment of Clinical Research, Instituto Fernandes Figueira, Fiocruz, Rio de Janeiro, Brazil.ORCID 0000-0002-2193-2224
Universidade de São Paulo · BRFundação Oswaldo Cruz · BRSeattle Children's Hospital · USUniversidade Federal Fluminense · BRUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the 2015 to 2016 outbreak in America, Zika virus (ZIKV) infected almost 900,000 patients. This international public health emergency was mainly associated with a significant increase in the number of newborns with congenital microcephaly and abnormal neurologic development, known as congenital Zika syndrome (CZS). Furthermore, Guillain-Barré syndrome (GBS), a neuroimmune disorder of adults, has also been associated with ZIKV infection. Currently, the number of ZIKV-infected patients has decreased, and most of the cases recently reported present as a mild and self-limiting febrile illness. However, based on its natural history of a typical example of reemerging pathogen and the lack of specific therapeutic options against ZIKV infection, new outbreaks can occur worldwide, demanding the attention of researchers and government authorities. Here, we discuss the clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations. Several studies have confirmed the tropism of ZIKV for neural progenitor stem cells by demonstrating the presence of ZIKV in the central nervous system (CNS) during fetal development, eliciting a deleterious inflammatory response that compromises neurogenesis and brain formation. Of note, while the neuropathology of CZS can be due to a direct viral neuropathic effect, adults may develop neuroimmune manifestations such as GBS due to poorly understood mechanisms. Antiganglioside autoantibodies have been detected in multiple patients with ZIKV infection-associated GBS, suggesting a molecular mimicry. However, further additional immunopathological mechanisms remain to be uncovered, paving the way for new therapeutic strategies.

Indexed as

AnimalsBrainFemaleGuillain-Barre SyndromeHumansMiceMicrocephalyNeural Stem CellsPregnancyPregnancy Complications, InfectiousZika VirusZika Virus Infection

Identifiers

PMID34351896
PMCPMC8341629
OpenAlexW3189202393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.